{"url_path":"/sec/mnov/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 OTHER INFORMATION.","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1226616/0001193125-26-224066-index.html","accession_number":"0001193125-26-224066","cik":"0001226616","ticker":"MNOV","issuer_name":"MEDICINOVA INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1226616/0001193125-26-224066-index.html","primary_entity_key":"0001226616","primary_entity_name":"MEDICINOVA INC"},"word_count":58,"has_tables":true,"body_markdown":"ITEM 5. OTHER INFORMATION.\n\nSecurities Trading Plans of Directors and Executive Officers\n\nDuring the quarter ended March 31, 2026, none of our officers or directors, as defined in Rule 16a-1(f), informed us of the adoption or termination of a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement, each as defined in Regulation S-K Item 408.\n\n \n\n \n\n22"}